- Supported exchanges /
- F /
- BT1.F
Bone Therapeutics SA (BT1 F) stock market data APIs
BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.
Bone Therapeutics SA Financial Data Overview
0.0114 | |
0.0057 | |
- | |
0.0114 | |
0.0057 | |
0.001-0.092 | |
3 506 K | |
266 M | |
2 872 K | |
-3.082 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Bone Therapeutics SA Fundamental Data is available in our Financial Data APIs
- Net Revenue 2 872 K
- EBITDA -3 357 000
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Bone Therapeutics SA Earnings via APIs
- Latest Release 2024-10-28
- EPS/Forecast NaN
Get Bone Therapeutics SA End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: